Nifty

:

22795.90

Sensex

:

75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Login

Nifty
Sensex

:
:

22795.90
75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Veerhealth Care Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 511523 | NSE: NIYATILEAS

Watchlist

NSE BSE

18.44

06-Feb-2025

Open
High
Low
Previous Close

18.50
18.96
18.05
18.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

13928
2.58
29.40
14.90

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

29.96
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

29.47
N/A
1.34

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

25.82
2.42
11.14

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-2.15
-

PAT CAGR (%)

10 Years
5 Years
3 Years

21.19
5.08
-

P:E (Median)

8 Years
5 Years
3 Years

23.01
21.55
62.15

P:BV (Average)

8 Years
5 Years
3 Years

1.04
1.04
1.40

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.07
14.09
17.42

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 3.84 2.87 33.80% 5.15 3.83 34.46% 2.06 3.58 -42.46% 3.37 3.73 -9.65%
Expenses 3.69 2.69 37.17% 4.66 3.61 29.09% 2.08 3.15 -33.97% 3.19 3.36 -5.06%
EBITDA 0.15 0.18 -16.67% 0.48 0.21 128.57% -0.01 0.43 - 0.17 0.38 -55.26%
EBIDTM 4.01% 6.20% 9.38% 5.62% -0.63% 12.09% 5.20% 10.04%
Other Income 0.18 0.24 -25.00% 0.25 0.42 -40.48% 0.36 0.14 157.14% 0.17 0.28 -39.29%
Interest 0.01 0.00 0 0.11 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.25 0.18 38.89% 0.20 0.18 11.11% 0.19 0.18 5.56% 0.18 0.16 12.50%
PBT 0.07 0.23 -69.57% 0.42 0.45 -6.67% 0.15 0.40 -62.50% 0.16 0.49 -67.35%
Tax 0.00 0.04 -100.00% 0.12 0.06 100.00% 0.03 0.06 -50.00% 0.71 -0.56 -
PAT 0.07 0.19 -63.16% 0.30 0.39 -23.08% 0.12 0.34 -64.71% -0.55 1.04 -
PATM 1.80% 6.62% 5.81% 10.24% 5.91% 9.55% -16.45% 27.99%
EPS 0.03 0.10 -70.00% 0.15 0.20 -25.00% 0.06 0.17 -64.71% -0.28 0.52 -

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 14.42 13.22 13.27 9.63 10.58 11.73 5.98 5.17 1.92 2.17 1.33 Net Sales Growth 2.93% -0.38% 37.80% -8.98% -9.80% 96.15% 15.67% 169.27% -11.52% 63.16% Cost Of Goods Sold 9.23 9.13 9.23 6.92 7.52 7.88 3.79 3.67 1.16 0.92 0.73 Gross Profit 5.19 4.09 4.04 2.70 3.06 3.84 2.19 1.49 0.76 1.26 0.60 GP Margin 36.01% 30.94% 30.44% 28.04% 28.92% 32.74% 36.62% 28.82% 39.58% 58.06% 45.11% Total Expenditure 13.62 12.61 12.78 10.46 10.55 11.05 5.54 5.29 2.28 2.19 1.49 Power & Fuel Cost - 0.24 0.20 0.20 0.25 0.22 0.10 0.11 0.07 0.08 0.09 % Of Sales - 1.82% 1.51% 2.08% 2.36% 1.88% 1.67% 2.13% 3.65% 3.69% 6.77% Employee Cost - 1.31 0.90 0.88 0.83 0.80 0.47 0.57 0.58 0.47 0.43 % Of Sales - 9.91% 6.78% 9.14% 7.84% 6.82% 7.86% 11.03% 30.21% 21.66% 32.33% Manufacturing Exp. - 0.22 0.41 0.73 1.37 1.03 0.22 0.24 0.16 0.19 0.15 % Of Sales - 1.66% 3.09% 7.58% 12.95% 8.78% 3.68% 4.64% 8.33% 8.76% 11.28% General & Admin Exp. - 0.61 0.59 0.46 0.78 1.06 0.59 0.50 0.22 0.61 0.16 % Of Sales - 4.61% 4.45% 4.78% 7.37% 9.04% 9.87% 9.67% 11.46% 28.11% 12.03% Selling & Distn. Exp. - 0.71 1.10 0.94 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 5.37% 8.29% 9.76% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 0.40 0.35 0.32 0.06 0.29 0.47 0.31 0.16 0.01 0.00 % Of Sales - 3.03% 2.64% 3.32% 0.57% 2.47% 7.86% 6.00% 8.33% 0.46% 1.50% EBITDA 0.79 0.61 0.49 -0.83 0.03 0.68 0.44 -0.12 -0.36 -0.02 -0.16 EBITDA Margin 5.48% 4.61% 3.69% -8.62% 0.28% 5.80% 7.36% -2.32% -18.75% -0.92% -12.03% Other Income 0.96 1.39 1.25 1.68 1.23 0.48 0.29 0.72 0.72 0.38 0.49 Interest 0.12 0.01 0.00 0.09 0.22 0.19 0.03 0.07 0.10 0.13 0.06 Depreciation 0.82 0.71 0.62 0.52 0.47 0.32 0.32 0.27 0.23 0.21 0.11 PBT 0.80 1.28 1.12 0.24 0.58 0.65 0.38 0.25 0.03 0.02 0.16 Tax 0.86 0.88 -0.47 0.31 0.20 0.33 0.22 0.11 0.01 0.01 0.10 Tax Rate 107.50% 68.75% -41.96% 129.17% 34.48% 50.77% 57.89% 44.00% 33.33% 50.00% 62.50% PAT -0.06 0.41 1.58 -0.07 0.38 0.32 0.16 0.14 0.02 0.01 0.06 PAT before Minority Interest -0.06 0.41 1.58 -0.07 0.38 0.32 0.16 0.14 0.02 0.01 0.06 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -0.42% 3.10% 11.91% -0.73% 3.59% 2.73% 2.68% 2.71% 1.04% 0.46% 4.51% PAT Growth -103.06% -74.05% - - 18.75% 100.00% 14.29% 600.00% 100.00% -83.33% EPS -0.03 0.21 0.79 -0.04 0.19 0.16 0.08 0.07 0.01 0.01 0.03

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 21.84 21.43 13.95 14.04 13.76 13.28 13.10 12.85 12.82 12.80 Share Capital 20.00 10.00 6.93 6.93 6.93 6.93 6.93 6.93 6.93 6.93 Total Reserves 1.84 11.43 7.02 7.11 6.82 6.35 6.17 5.92 5.88 5.86 Non-Current Liabilities 3.50 2.85 3.74 3.11 2.73 0.30 0.43 0.55 0.77 0.73 Secured Loans 0.00 0.00 0.00 1.41 2.04 0.00 0.21 0.44 0.67 0.65 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.38 0.13 0.16 0.16 0.06 0.04 0.08 0.03 0.02 0.01 Current Liabilities 2.77 0.97 2.46 1.58 1.49 2.58 1.21 -0.35 0.53 0.51 Trade Payables 2.16 0.55 2.32 0.92 0.84 1.57 0.19 0.22 0.08 0.11 Other Current Liabilities 0.29 0.17 0.11 0.05 0.06 0.07 0.01 0.04 0.03 0.00 Short Term Borrowings 0.00 0.00 0.00 0.32 0.44 0.94 1.01 -0.61 0.41 0.36 Short Term Provisions 0.33 0.25 0.04 0.29 0.16 0.00 0.00 0.01 0.01 0.04 Total Liabilities 28.11 25.25 20.15 18.73 17.98 16.16 14.74 13.05 14.12 14.04 Net Block 11.97 12.01 10.54 9.48 9.45 5.46 5.54 2.52 2.71 2.07 Gross Block 16.03 15.05 12.96 11.37 10.88 6.62 6.41 3.11 3.07 2.23 Accumulated Depreciation 4.06 3.04 2.42 1.89 1.43 1.16 0.86 0.59 0.36 0.16 Non Current Assets 14.66 14.91 13.92 11.89 11.81 13.27 7.86 5.12 7.34 5.66 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 2.19 0.24 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 2.69 2.90 3.38 2.41 2.36 5.62 2.07 2.57 4.59 3.59 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.03 0.00 Current Assets 13.46 10.34 6.23 6.84 6.18 2.89 6.88 7.94 6.78 8.34 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 1.40 2.61 2.12 1.66 1.23 0.84 0.94 1.53 1.12 0.46 Sundry Debtors 3.92 1.84 1.54 1.54 0.94 0.74 0.92 0.61 0.89 0.93 Cash & Bank 0.24 3.61 0.40 0.10 0.02 0.18 0.08 0.02 0.10 0.11 Other Current Assets 7.90 0.00 0.00 0.00 3.99 1.13 4.94 5.77 4.67 6.85 Short Term Loans & Adv. 7.90 2.29 2.16 3.53 3.99 1.13 4.67 5.31 4.18 2.46 Net Current Assets 10.68 9.37 3.77 5.26 4.68 0.31 5.67 8.29 6.25 7.84 Total Assets 28.12 25.25 20.15 18.73 17.99 16.16 14.74 13.06 14.12 14.03

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 2.90 -0.70 1.81 1.00 -0.36 1.98 1.76 1.69 0.00 -3.73 PBT 1.29 1.05 0.26 0.47 0.65 0.38 0.25 0.03 0.02 0.06 Adjustment 0.47 0.53 0.10 0.37 0.21 0.32 -0.09 -0.07 -0.27 -0.38 Changes in Working Capital 1.42 -2.08 1.49 0.39 -1.15 1.41 1.70 0.95 0.24 -3.48 Cash after chg. in Working capital 3.18 -0.50 1.85 1.24 -0.30 2.11 1.86 0.90 0.00 -3.80 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.28 -0.20 -0.04 -0.23 -0.06 -0.13 -0.10 0.78 0.00 0.07 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -0.28 -1.79 -1.09 -0.09 -1.67 -1.90 -3.02 -0.44 -0.01 3.85 Net Fixed Assets -0.98 -2.09 -1.59 -0.49 -2.07 -2.16 -3.54 -0.04 -0.84 2.73 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.70 0.30 0.50 0.40 0.40 0.26 0.52 -0.40 0.83 1.12 Cash from Financing Activity -5.99 5.69 -0.42 -0.83 1.85 0.02 1.31 -1.33 0.00 0.00 Net Cash Inflow / Outflow -3.37 3.21 0.30 0.09 -0.17 0.10 0.06 -0.08 -0.01 0.12 Opening Cash & Equivalents 3.61 0.40 0.10 0.02 0.18 0.08 0.02 0.10 0.11 -0.01 Closing Cash & Equivalent 0.24 3.61 0.40 0.10 0.02 0.18 0.08 0.02 0.10 0.11

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 10.92 10.72 10.06 20.25 19.84 19.16 18.89 18.53 18.48 18.41 ROA 1.52% 6.97% -0.38% 2.07% 1.86% 1.02% 0.99% 0.17% 0.06% 0.42% ROE 1.88% 8.94% -0.53% 2.73% 2.35% 1.20% 1.06% 0.18% 0.07% 0.45% ROCE 5.96% 6.32% 2.17% 4.97% 5.50% 2.89% 2.38% 1.00% 1.13% 1.62% Fixed Asset Turnover 0.85 0.95 0.79 0.95 1.34 0.92 1.09 0.62 0.82 0.37 Receivable days 79.49 46.47 58.50 42.78 26.13 50.68 53.93 142.08 152.37 138.36 Inventory Days 55.23 65.03 71.80 49.91 32.23 54.32 87.40 252.50 133.21 76.45 Payable days 54.17 56.80 85.29 42.57 55.82 67.03 17.20 20.63 13.47 19.20 Cash Conversion Cycle 80.55 54.70 45.00 50.11 2.54 37.98 124.14 373.96 272.12 195.60 Total Debt/Equity 0.00 0.00 0.00 0.12 0.18 0.07 0.09 -0.01 0.08 0.08 Interest Cover 169.61 860.15 3.79 3.64 4.40 11.97 4.54 1.31 1.18 3.80

Top Investors:

deval nilay shah

hardik indramal jain

veerhealth care limited suspense escrow

Annual Reports:

News Update:

Veerhealth Care introduces new marketing division of hospital care segment
18th Dec 2024, 16:49 PM

This manufacturing Company mainly caters in the field of Operating Room, Critical Care, Life Support, Imaging and Mobile Healthcare
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback